Biomaterials Market

Biomaterials Market (Distribution by Products (Metallic, Natural, Ceramics, Polymers and Other Products), by Applications (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Neurological Disorder, Drug Delivery System and Other Applications) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Pages

  • View Count

Biomaterials Market Overview 2023-2035

The biomaterials market is a dynamic and rapidly evolving sector at the intersection of materials science, biology, and healthcare. Biomaterials, ranging from synthetic polymers to natural substances, play a pivotal role in various medical applications, including implants, tissue engineering, and drug delivery systems. As technological advancements continue to drive innovation, the biomaterials market is poised for significant growth, influencing the landscape of modern medicine and contributing to advancements in regenerative medicine and personalized healthcare.

Biomaterials are substances engineered to interact with biological systems for medical purposes, such as therapeutic or diagnostic applications. They are designed to be compatible with living tissue and the environment and can be derived from natural sources or synthetic sources. Biomaterials are used in various medical applications, including implants, prosthetics, cardiovascular devices, drug delivery systems, wound dressings, and tissue engineering. They play a crucial role in replacing or repairing damaged body parts, allowing patients to regain mobility and improve their quality of life. Ongoing research aims to develop biomaterials with improved biocompatibility, mechanical strength, and degradation rates, leading to the creation of innovative treatments and devices in medicine. The field of biomaterials combines medicine, biology, physics, and chemistry, with influences from tissue engineering and materials science.

Market Drivers

The growth drivers in the biomaterials market include an increase in the geriatric population, a rise in the prevalence of cardiovascular and orthopedic disorders, advancements in medical technology, and an increase in awareness regarding implantable devices. Furthermore, heavy government funding to increase research and development activities in the field of biomaterials, as well as the increasing applications of biomaterials in wound care, sports injuries, and plastic surgery, are contributing to the market's growth. Additionally, innovations in the field of biomaterials and the growing implant devices and biomaterials market are also driving market growth.

Market Restraints

Market restraints in the biomaterials market include the high cost of biomaterial implants and compatibility issues. These factors are expected to hinder the growth of the market despite the driving forces such as advancements in medical technology and an increase in awareness regarding implantable devices. Additionally, economic constraints in emerging countries and business market obstacles are identified as key market restraints. The high cost of cellular allograft products is also mentioned as a hindrance to new entrants in the market. These restraints pose challenges to businesses operating in the biomaterials market, requiring them to develop strategies to mitigate these obstacles and achieve long-term success.

Market Opportunities

The biomaterials market in emerging countries is expected to experience significant growth owing to various factors such as the increasing patient population, rising adoption of implantable devices, growing awareness of cardiovascular diseases, rising disposable income, improving healthcare infrastructure, and the presence of less-stringent regulatory guidelines compared to developed countries. Brazil, Russia, India, China, and South Africa are among the fastest-growing economies in the world, and the growing demand for surgical procedures, rising geriatric population, and the increasing incidence of target diseases are expected to drive the demand for advanced healthcare services and novel medical devices in these countries, offering potential growth opportunities to market players. The global biomaterials market is projected to reach multimillion figures by 2030, displaying an unexpected compound annual growth rate, with Asia-Pacific offering profitable opportunities for key players operating in the biomaterials market.

Biomaterials Market Segments Overview

The biomaterials market forecast on the basis of products (metallic, natural, ceramics, polymers and other products). On the basis of applications (cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, neurological disorder, drug delivery system and other applications). By geographical regions, the market is analyzed across North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.

Application Analysis Section

Based on applications, the biomaterials market is analyzed across cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, neurological disorder, drug delivery system and other applications. The orthopedic application segment is expected to be the dominant force in the biomaterials market in terms of revenue. The increasing adoption of metallic biomaterials in orthopedic applications owing to their high load-bearing capacity is a key factor driving the segment's growth. Additionally, continuous developments for the introduction of advanced orthopedic implants by market vendors are also expected to propel revenue generation. Furthermore, the plastic surgery segment is anticipated to grow at the fastest CAGR during 2023-2030 attributing to the increasing number of cosmetic procedures and the increased usage of biomaterials in these surgeries. For instance, in the US, around 4.3 million cosmetic procedures were performed in 2018, positively influencing segment growth.

Regional Analysis Section

Based on region, the biomaterials market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to have the largest share in the biomaterials market owing to various initiatives by public and private organizations, such as the National Science Foundation and the National Institute of Standards and Technology, which provide knowledge and assistance related to biomaterials usage in biomedical applications. This has led to an expansion of biomaterials adoption in the region.

Additionally, favorable government policies and the presence of major market players have contributed to the regional market share. Moreover, Asia Pacific is anticipated to register the highest compound annual growth rate during 2023-2030, driven by strategic initiatives adopted by regional participants to strengthen their presence in local and global markets. Further in India, the biomaterials market is thriving, particularly in the orthopedic, dental, and cardiovascular segments, attributed to the increasing market shares of these products driven by a rise in orthopedic surgery, cardiovascular surgeries, and dental procedures.

Top Companies Engaged in Biomaterials Market

Key market players that are engaged in biomaterials market are (in alphabetical order) Berkeley Advanced Biomaterials, Collagen Matrix, CoorsTek, Covalon Technologies, Evonik Industries, Invibio, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Holdings. This market report includes an easily searchable excel database of all the biomaterials companies worldwide.

Biomaterials Market Report Highlights

Aspects Details
by Products
  • Metallic
  • Natural
  • Ceramics
  • Polymers 
  • Other Products
by Application
  • Cardiovascular
  • Dental
  • Orthopedic
  • Wound Healing
  • Plastic Surgery
  • Ophthalmology
  • Neurological Disorder
  • Drug Delivery System 
  • Other Applications
Key Geographical Regions
  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players
  • Berkeley Advanced Biomaterials
  • Collagen Matrix
  • CoorsTek
  • Covalon Technologies
  • Evonik Industries
  • Invibio
  • Johnson & Johnson
  • Medtronic
  • Stryker
  • Zimmer Biomet Holdings


Recent Developments in Biomaterials Market

There has been recent activity in the biomaterials industry and some of the key developments have been mentioned below:

  • In August 2023, CJ Biomaterials entered into a supply agreement with Riman in order to provide eco-friendly packaging material to the products of the latter company.
  • In November 2022, CJ Biomaterials announced a strategic collaboration with NatureWorks, aiming to develop high-performance biopolymer solutions intended to replace fossil-fuel based plastics in various applications, including compostable food packaging, food serviceware, personal care products, films, and other end products.


This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team.